Effect of high dose of steroid on plateletcount in acute stage of dengue fever with thrombocytopenia

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 7, 2013, Pages 1397-1400

  Shashidhara, K C ^a   Sudharshan Murthy, K A ^a   Basavana Gowdappa, H ^a   Bhograj, Abhijith ^a  

^a JSS MEDICAL COLLEGE   (India)

Author keywords

Dengue fever; Dexamethasone; DHF; DSS; Thrombocytopenia

Indexed keywords

ANTIPYRETIC AGENT; DEXAMETHASONE; IMMUNOGLOBULIN M; PARASITE ANTIGEN;

ACUTE DISEASE; ADULT; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUID THERAPY; HEMATOCRIT; HUMAN; INDIA; MALE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 84879962424     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/6135.3143     Document Type: Article

References (29)

1. WHO. Dengue Guideline for diagnosis, treatment, Prevention and control. Geneva: World Health Organization. 2009.
2. Guzman MG, Kauri G. Dengue: an update. The Lancet Infectious Diseases. 2002; 2: 33-42.
3. Stasi R, Provan D. Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc. 2004; 79: 504-22.
4. Messer WB, Vitarana UT, Sivananthan K, et al.Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg. 2002; 66:765-73.
5. Kularatne SAM. Survey on the management of dengue infection in Sri Lanka: Opinion of physicians and pediatricians. Southeast Asian J Trop Med Pub Health. 2005; 36: 1198-200.
6. Halstead SB. Dengue. Lancet. 2007; 370: 1644-52.
7. Panpanich R, Sornchai P, Kanjanaratanakorn K. Corticosteroids for treating dengueshock syndrome. Cochrane Database of Systematic. Reviews. 2006; (issue 3):CD003488.
8. Douglas B, Cines MD, Victor S, et al. Immune thrombocytopenic purpura. N Engl J Med. 2002; 346: 995-1008.
9. Rajapakse S. Corticosteroids in the treatment of dengue illness. Trans R Soc Trop Med Hyg. 2009;103:122-26.
10. Kularatne S A M, Walathara C, Mahindawansa S I, et al.Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study. Postgrad Med J. 2009;85:525-292.
11. Matti S Aapro, Alberts S.High dose of Dexamethasone for prevention of cis-platin-induced vomiting. Cancerche mother pharmacol.1981;7: 11-14.
12. Gupta E, Dar L, Narang P, Srivastava VK, Broor S.Serodiagnosis of dengue during an outbreak at a tertiary care hospital in Delhi. Indian J Med Res. 2005;121: 36-38.
13. Aneja R, Carcillo JA. What is the rationale for hydrocortisone treatment in children with infectionrelated adrenal insufficiency and septic shock? Arch Dis Child. 2007; 92:165-69.
14. Min M, UT, Aye M, et al. Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health. 1975;6:573-79.
15. Sumarmo, Talogo W, Asrin A, et al. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics. 1982;69:459.
16. Tassniyom S, Vasanawathana S, Chirawatkul A, et al. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics. 1993;92:111.
17. Kularatne SAM, Pathirage MMK, Walathara C, et al.Value of dexamethasone in severe thrombocytopenia caused by dengue fever: a randomized, double blind, placebo controlled study. Proceedings of the Kandy Society of Medicine, 29th Annual Academic Sessions. Kandy, Sri Lanka: 2007.
18. Futrakul P, Poshyachinda M, Mitrakul C, et al. Hemodynamic response to high-dose methyl prednisolone and mannitol in severe dengue-shock patients unresponsive to fluid replacement. South East Asian J Trop Med Public Health.1987; 18:373-79.
19. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288:862-70.
20. Sprung CL, Annane D, Keh D, et al; for the Corticus Study Group. The CORTICUS randomized,double-blind, placebo-controlled study of hydrocortisone therapy in patients with septic shock. N Engl J Med. 2008; 358:111-24.
21. Marik PE, Pastores SM, Annane D, et al. Clinical practice guidelines for the diagnosis and management of corticosteroid insufficiency in critical illness: Recommendations of an international task force. Crit Care Med. 2008; 36:1937-49.
22. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults-A systematic review. JAMA. 2009; 301:2362-75.
23. Sligl WI, Milner DA, Sundar S, et al. Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis. Clin Infect Dis. 2009; 49:93-101.
24. Minneci PC, Deans KJ, Eichacker PQ, et al.The effects of steroids during sepsis depend on dose and severity of illness: An updated meta-analysis. Clin Microbiol Infect. 2009;15:308-18.
25. Sprung CL, Caralis PV, Marcial EH, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med.1984; 311:1137-43.
26. Bone RC, Fisher CJ Jr, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med.1987;317:653-58.
27. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med.1987; 317:659-65.
28. Lefering R, Neugebauer EAM. Steroid controversy in sepsis and septic shock: A metaanalysis. Crit Care Med. 1995; 23:1294-303.
29. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med. 1995; 24:1430-39.